Clinical outcomes of ultra-long acting insulin analogues: impact on hypoglycaemia

This session will assess the comparative data on hypoglycaemic profiles of the two current ultra long-acting basal analogue insulins available outlining the differences, benefits and place in therapy.

Learning outcomes:

  • Attendees will be able to see the benefits of both Insulins and place in therapies
  • Attendees will be helped in the design of local pathways including these insulins
  • Attendees will be helped to see the differences and similarities of these two basal insulins

Prescribing information can be found here.

SAGB.DIA.18.10.1641                                                                                                                     DoP Oct 2018

This promotional session has been organised by Sanofi and the speaker remunerated by Sanofi

Wednesday 14th November 2018

12:50 - 13:20

Hypo Hub

Speakers

Dr Pratik Choudhary
Clinical lead for T1 Diabetes, Islet & Pancreas transplantation, Consultant in Diabetes, King's College Hospital

Our site is intended for UK Healthcare Professionals

Are you a UK Healthcare Professional?

We’re sending you to our partner charity’s site. 

DRWF provide information and support for people with diabetes and their friends & families